P124 Long-term safety of radium-223 dichloride (Ra-223) in patients with castration-resistant prostate cancer (CRPC) and bone metastases from the phase 3 ALSYMPCA study
Nilsson, S, Schrader, A.J., Kliment, J., Solberg, A., Franzén, L., Bottomley, D., Syndikus, I., Parker, C., Sartor, O., Skjørestad, I., Jensen, T., Shan, M., Coleman, R.Volume:
12
Language:
english
Journal:
European Urology Supplements
DOI:
10.1016/S1569-9056(13)62445-8
Date:
November, 2013
File:
PDF, 66 KB
english, 2013